CONSERVE Plus Post-Approval Study (PAS)

计划入组 199 人 · 首次发布于 2011 年 6 月 7 日

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

计划入组 12 人 · 首次发布于 2023 年 8 月 23 日

Treatment With Namenda in Women at Risk for Cognitive Decline

计划入组 22 人 · 首次发布于 2005 年 10 月 20 日

Kaempferia galanga root

Anti-HIF-2alpha siRNA therapy (Calando)

Tubulysin cancer therapeutics(Calando Pharmaceuticals/R&D-Biopharmaceuticals)

FERNANDEZ LOPEZ YOLANDA

Spain

Amrith Noni Artho Plus Demonstrates Efficacy in Arthritis Management in Clinical Trial

Ananda Developments' Cannabinoid Medicines to be Used in NHS Epilepsy Trials

Ananda Developments Enters Phase III Trials for Cannabis-Based Epilepsy Treatment